New drug PORT-77 put to the test in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a new drug, PORT-77, in 156 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and some doses were given with food. The goal was to gather safety information, not to treat any diseas…
Phase: PHASE1 • Sponsor: Portal Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 03:26 UTC